Presynaptic enzymatic neurotoxins

Ornella Rossetto1, Laura Morbiato, Paola Caccin

  • 1Dipartimento di Scienze Biomediche and Istituto CNR di Neuroscienze, Università di Padova, Padova, Italy. ornella.rossetto@unipd.it

Insights

Botulinum neurotoxins and snake venom toxins inhibit nerve function by targeting nerve terminals. These toxins offer potential therapeutic applications for managing hyperactive nerve conditions.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Toxicology

Background:

  • Botulinum neurotoxins (BoNTs), highly toxic proteins from Clostridium, cause botulism by cleaving neuroexocytosis proteins in nerve terminals, inhibiting neurotransmitter release.
  • These neurotoxins are therapeutically used for conditions involving hyperactive nerve terminals.
  • Snake presynaptic phospholipase A2 (PLA2) neurotoxins disrupt nerve terminal function by hydrolyzing phospholipids, altering membrane dynamics and neurotransmitter release.

Purpose of the Study:

  • To elucidate the mechanisms of action of botulinum neurotoxins and snake presynaptic PLA2 neurotoxins.
  • To explore the potential therapeutic applications of these neurotoxins and their byproducts.

Main Methods:

  • Analysis of the molecular mechanisms by which BoNTs inhibit neurotransmitter release.
  • Investigation of the effects of snake PLA2 neurotoxins on nerve terminal membrane structure and function.
  • Examination of phospholipid hydrolysis products (lysophospholipids and fatty acids) generated by PLA2.

Main Results:

  • Botulinum neurotoxins act as metalloproteinases, cleaving key proteins in the neuroexocytosis pathway.
  • Snake PLA2 neurotoxins induce both neurotransmitter release and subsequent inhibition of vesicle recycling through membrane alteration.
  • Lysophospholipids and fatty acids produced by PLA2 activity were identified as key mediators of these effects.

Conclusions:

  • Botulinum neurotoxins provide a model for understanding and treating conditions with excessive nerve activity.
  • Snake venom PLA2 neurotoxins offer insights into synaptic vesicle dynamics and neurotransmission.
  • The lysophospholipid/fatty acid mixture generated by PLA2 has potential for therapeutic use in inhibiting superficial hyperactive nerve terminals.

Related Concept Videos

Fusion of Secretory Vesicles with the Plasma Membrane01:26

Fusion of Secretory Vesicles with the Plasma Membrane

Proteins and neurotransmitters in secretory vesicles can be released from a cell upon vesicle docking, priming, and fusion with the plasma membrane. Vesicles are docked and primed in preparation for the quick exocytosis of their contents in response to a stimulus. The fusion process is mainly carried out by a SNAP Receptor or SNARE complex, consisting of synaptobrevin, syntaxin-1, and SNAP-25.
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
15.9K
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
9.5K
Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.5K
Cholinergic Neurons: Neurotransmission01:23

Cholinergic Neurons: Neurotransmission

Cholinergic neurotransmission involves the synthesis and the release of acetylcholine (ACh) in order to transmit nerve impulses across the synapse. The process begins with the synthesis of acetyl CoA, a precursor for ACh, from ATP, acetate, and coenzyme A in the mitochondria. Choline, another vital precursor, is transported inside the neuron through choline transporters, including high-affinity choline transporter CHT1, low-affinity choline transporter CTL1, and lower-affinity choline...
6.0K
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
10.9K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.5K